HIGHLIGHTS
- who: John A. Snowden from the (UNIVERSITY) have published the Article: Indications for haematopoietic cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe,, in the Journal: (JOURNAL) of 19/05/2022
- what: The aim of CML therapy should be to prevent progression to the advanced phase or >CP1, as outcomes posttransplantation are worse in those situations.
- how: This revised scoring system is based on marrow blast percentage modified cytogenetic risk groups and severity of cytopenias.
- future: Despite the encouraging role of immune surveillance and immune_responses against . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.